Metabolic comorbidities, including obesity and type 2 diabetes increase the risk of morbidity and mortality in patients who contract coronavirus disease 2019 (Covid-19). But findings published in the journal Nature show that not only are patients with diabetes more at risk of more severe outcomes, patients without diabetes who develop Covid-19 may also be at a higher risk of actually developing diabetes following recovery.
BioNTech SE could have capacity to make 3 billion doses of the Covid-19 vaccine the company developed with partner Pfizer Inc. during 2022, Bloomberg News reported on March 9, citing an interview with the German company’s chief executive officer.
The data continues to come in on the various Covid-19 variants, and so far the news is pretty good, according to BioSpace.
Pfizer Inc. and partner BioNTech Se are developing a booster shot to protect against Covid-19 variants.
AstraZeneca is likely to run an additional global trial to assess the efficacy of the company’s Covid-19 vaccine using a lower dosage, the British drugmaker’s chief executive was quoted as saying amid questions over the results of a late-stage study.
Shares of Gilead Sciences rose following a report that the company was approached by U.K. pharma giant AstraZeneca regarding a potential merger.
As Sanofi continues to undergo a planned renovation announced in December 2019, the company will do so without four long-time executives.
The U.S. Department of Health and Human Services shelved a proposal to drastically cut the level of nicotine in cigarettes, Bloomberg reported citing a regulatory document.
